FDA Inspection 681162 — Adolor Corporation
The FDA completed an inspection of Adolor Corporation on September 17, 2010 in Exton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 17, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Exton, PA (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)